Methyl 3'-Amino-1,1'-biphenyl-3-carboxylate Hydrochloride - CAS 343985-94-4
Catalog: |
BB059919 |
Product Name: |
Methyl 3'-Amino-1,1'-biphenyl-3-carboxylate Hydrochloride |
CAS: |
343985-94-4 |
Synonyms: |
3'-Amino-[1,1'-biphenyl]-3-carboxylic Acid Methyl Ester Hyrochloride; Methyl 3'-Amino-1,1'-biphenyl-3-carboxylate Hyrochoride; Methyl 3'-Aminobiphenyl-3-carboxylate Hydrochloride |
IUPAC Name: | methyl 3-(3-aminophenyl)benzoatehydrochloride |
Description: | Methyl 3'-Amino-1,1'-biphenyl-3-carboxylate Hydrochloride is a useful reagent for organic synthesis and other chemical processes. |
Molecular Weight: | 227.26 + (36.46) |
Molecular Formula: | C14H13NO2·(HCl) |
Canonical SMILES: | COC(=O)C1=CC=CC(=C1)C2=CC(=CC=C2)N.Cl |
InChI: | InChI=1S/C14H13NO2.ClH/c1-17-14(16)12-6-2-4-10(8-12)11-5-3-7-13(15)9-11/h2-9H,15H2,1H31H |
InChI Key: | IAJUBUSGJJAXPO-UHFFFAOYSA-N |
Melting Point: | >179°C (dec.) |
Solubility: | DMSO (Slightly), Methanol (Very Slightly) |
Appearance: | White Solid |
Storage: | -20°C Freezer |
References: | Uehling, D. E., et al. J. Med. Chem., 49, 2758 (2006); Kuppusamy, R., et al. Eur. J. Med. Chem., 143, 1702 (2018). |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
BR-PI0016187-B1 | process for the preparation of aryl ethanol amine derivatives having anti-obesity and anti-diabetic properties | 19991211 |
CA-2394117-C | Process for the preparation of arylethanolamine derivatives having anti-obesity and anti-diabetic properties | 19991211 |
CZ-20022017-A3 | Process for the preparation of arylethanolamine derivatives with antiobesity and antidiabetic properties | 19991211 |
CZ-303143-B6 | A method for producing arylethanolamine derivatives with antiobesity and antidiabetic properties | 19991211 |
DE-60019157-T2 | METHOD OF PREPARING ARYLETHANOLAMINE DERIVATIVES FOR THE TREATMENT OF DIABETES AND FATIBILITY | 19991211 |
EP-1235788-B1 | Process for the preparation of arylethanolamine derivatives having an anti-obesity and anti-diabetic properties | 19991211 |
HU-0203640-A2 | Process for the preparation of (aryl-ethanol) -amine derivatives having anti-obesity and antidiabetic properties \ t | 19991211 |
JP-2003516383-A | Method for preparing arylethanolamine derivatives having anti-obesity and anti-diabetic properties | 19991211 |
JP-4903964-B2 | Process for the preparation of arylethanolamine derivatives having anti-obesity and anti-diabetic properties | 19991211 |
KR-100683614-B1 | Process for preparing arylethanolamine derivatives having anti-obesity and anti-diabetic properties | 19991211 |
Complexity: | 267 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 2 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 263.0713064 |
Formal Charge: | 0 |
Heavy Atom Count: | 18 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 263.0713064 |
Rotatable Bond Count: | 3 |
Topological Polar Surface Area: | 52.3Ų |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
-
Catalog: BB069928
((2S,4R)-2-(Chloromethyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methyl 4-Methylbenzenesulfonate
Detail
-
Catalog: BB075348
((2S,3S,4R,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl dihydrogen phosphate, sodium salt
Detail
-
Catalog: BB069927
((2R,4S)-2-(Chloromethyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methyl 4-Methylbenzenesulfonate
Detail
-
Catalog: BB064244
((2S,3R)-4-(4-(((((3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl)oxy)carbonyl)amino)-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-yl)carbamic Acid Phenylmethyl Ester
Detail
-
Catalog: BB061033
((2R,5S,10aS,10bS)-10b-Hydroxy-5-isopropyl-2-methyl-3,6-dioxooctahydro-2H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)carbamic Acid Benzyl Ester
Detail
-
Catalog: BB074488
((1R,3R)-3-Amino-cyclopentyl)-carbamic Acid tert-Butyl Ester
Detail
-
Catalog: BB069924
((2S,4S)-2-(Chloromethyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methyl 4-Methylbenzenesulfonate
Detail
-
Catalog: BB072639
((2R,3S,4R,5R)-5-(4-(Benzyloxy)-2-oxopyridin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl Dihydrogen Phosphate
Detail
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
Customers Also Viewed
-
[137076-54-1]
DOTA-tris(tert-butyl ester)
-
[1388152-02-0]
1,2-Cyclopentanediol, 3-amino-5-[(phosphonooxy)methy]-, ammonium salt (1:2), (1R,2S,3R,5R)-
-
[784-04-3]
9-Acetylanthracene
-
[80935-59-7]
(Benzene-1,3,5-triyl)triacetonitrile
-
[7310-97-6]
2,5-Dimethoxybenzene-1,4-dicarboxaldehyde
-
[2093414-16-3]
1,1'-Bis[3-(trimethylammonio)propyl]ferrocene dichloride
INDUSTRY LEADERS TRUST OUR PRODUCTS